<DOC>
	<DOCNO>NCT00204685</DOCNO>
	<brief_summary>The purpose study determine whether Inhalation Recombinant Human Deoxyribonuclease Shortens Ventilation Time Mechanically Ventilated Adults</brief_summary>
	<brief_title>Time Ventilation Lung Function Ventilated Patients Under Therapy With Dornase Alfa</brief_title>
	<detailed_description>Recombinant human deoxyribonuclease I ( rhDNase , dornase alpha ) , administer inhalation , currently use mucolytic agent treatment cystic fibrosis . This prospective , randomize , placebo-controlled , double-blind clinical study carry whether therapeutic use rhDNase extend adult undergo long term ventilation intensive care . It hypothesize mechanically ventilated patient show elevated concentration DNA airway secretion , pathological DNA level reduce rhDNase . The primary clinical goal study establish wether ventilation time shortend inhalation rhDNAse ventilation time . hDNase ( verum ) compare equal amount 0.9 % saline solution ( placebo ) .</detailed_description>
	<criteria>adult mechanical ventilation expect ventilation time 3 day longer full therapy possible expectet ventilation time longer 21 day medicinal point view : patient wonÂ´t survive next 21 day concomitant pneumococcal disease ( like tuberculosis , carcinoma ) endotracheal bleed pneumothorax relief ( e.g . thoracic drainage ) pregnancy breast feed participation another clinical trail mechanical ventilation since 48 hour mechanical ventilation basis another reason operation , trauma pulmonary decompensation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>